Advertisement

Topics

Biosimilars in oncology in Europe

03:20 EST 1 Dec 2017 | Generics and Biosimilars Initiative

In the European Union (EU), a legal framework for approving biosimilars was established back in 2003. This framework allows for biosimilars to be approved using an abbreviated pathway centrally via the European Medicines Agency (EMA) [1].

Original Article: Biosimilars in oncology in Europe

NEXT ARTICLE

More From BioPortfolio on "Biosimilars in oncology in Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...